CONMED Share Holder Equity 2010-2022 | CNMD

CONMED share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
CONMED Annual Share Holder Equity
(Millions of US $)
2021 $785
2020 $709
2019 $710
2018 $662
2017 $631
2016 $581
2015 $585
2014 $581
2013 $606
2012 $607
2011 $573
2010 $587
2009 $577
CONMED Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $673
2022-03-31 $790
2021-12-31 $785
2021-09-30 $756
2021-06-30 $744
2021-03-31 $726
2020-12-31 $709
2020-09-30 $683
2020-06-30 $675
2020-03-31 $702
2019-12-31 $710
2019-09-30 $701
2019-06-30 $697
2019-03-31 $693
2018-12-31 $662
2018-09-30 $653
2018-06-30 $648
2018-03-31 $643
2017-12-31 $631
2017-09-30 $590
2017-06-30 $582
2017-03-31 $576
2016-12-31 $581
2016-09-30 $584
2016-06-30 $580
2016-03-31 $582
2015-12-31 $585
2015-09-30 $577
2015-06-30 $578
2015-03-31 $574
2014-12-31 $581
2014-09-30 $593
2014-06-30 $602
2014-03-31 $595
2013-12-31 $606
2013-09-30 $592
2013-06-30 $585
2013-03-31 $598
2012-12-31 $607
2012-09-30 $602
2012-06-30 $593
2012-03-31 $587
2011-12-31 $573
2011-09-30 $610
2011-06-30 $617
2011-03-31 $601
2010-12-31 $587
2010-09-30 $580
2010-06-30 $578
2010-03-31 $584
2009-12-31 $577
2009-09-30 $571
2009-06-30 $563
2009-03-31 $555
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $3.073B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $73.740B 21.42
McKesson (MCK) United States $51.687B 15.01
AmerisourceBergen (ABC) United States $30.494B 13.47
West Pharmaceutical Services (WST) United States $25.090B 38.20
Laboratory Of America Holdings (LH) United States $24.019B 10.51
Cardinal Health (CAH) United States $17.095B 13.13
Cooper (COO) United States $16.392B 25.23
Invacare (IVC) United States $0.035B 0.00